"Calcineurin Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds that inhibit or block the PHOSPHATASE activity of CALCINEURIN.
| Descriptor ID |
D065095
|
| MeSH Number(s) |
D27.505.519.389.174
|
| Concept/Terms |
Calcineurin Inhibitors- Calcineurin Inhibitors
- Protein Phosphatase-2B Inhibitors
- Protein Phosphatase 2B Inhibitors
- Protein Phosphatase 3 Inhibitors
- Calcineurin Antagonists
- Calcineurin Blockers
|
Below are MeSH descriptors whose meaning is more general than "Calcineurin Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Calcineurin Inhibitors".
This graph shows the total number of publications written about "Calcineurin Inhibitors" by people in this website by year, and whether "Calcineurin Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 1 | 1 |
| 2005 | 1 | 1 | 2 |
| 2007 | 2 | 0 | 2 |
| 2008 | 1 | 1 | 2 |
| 2012 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 1 | 2 | 3 |
| 2017 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Calcineurin Inhibitors" by people in Profiles.
-
Nutan F, Ortega-Loayza AG. Cutaneous Lupus: A Brief Review of Old and New Medical Therapeutic Options. J Investig Dermatol Symp Proc. 2017 10; 18(2):S64-S68.
-
Laurin LP, Gasim AM, Derebail VK, McGregor JG, Kidd JM, Hogan SL, Poulton CJ, Detwiler RK, Jennette JC, Falk RJ, Nachman PH. Renal Survival in Patients with Collapsing Compared with Not Otherwise Specified FSGS. Clin J Am Soc Nephrol. 2016 10 07; 11(10):1752-1759.
-
Garza-Mayers AC, McClurkin M, Smith GP. Review of treatment for discoid lupus erythematosus. Dermatol Ther. 2016 Jul; 29(4):274-83.
-
Laurin LP, Gasim AM, Poulton CJ, Hogan SL, Jennette JC, Falk RJ, Foster BJ, Nachman PH. Treatment with Glucocorticoids or Calcineurin Inhibitors in Primary FSGS. Clin J Am Soc Nephrol. 2016 Mar 07; 11(3):386-94.
-
Feely MA, Smith BL, Weinberg JM. Novel psoriasis therapies and patient outcomes, part 1: topical medications. Cutis. 2015 Mar; 95(3):164-8, 170.
-
Karam S, Wali RK. Current State of Immunosuppression: Past, Present, and Future. Crit Rev Eukaryot Gene Expr. 2015; 25(2):113-34.
-
Krapf D, O'Brien E, Maidag?n PM, Morales ES, Visconti PE, Arranz SE. Calcineurin regulates progressive motility activation of Rhinella (Bufo) arenarum sperm through dephosphorylation of PKC substrates. J Cell Physiol. 2014 Oct; 229(10):1378-86.
-
Olauson H, Lindberg K, Amin R, Sato T, Jia T, Goetz R, Mohammadi M, Andersson G, Lanske B, Larsson TE. Parathyroid-specific deletion of Klotho unravels a novel calcineurin-dependent FGF23 signaling pathway that regulates PTH secretion. PLoS Genet. 2013; 9(12):e1003975.
-
Schaufler C, Lerer T, Campbell B, Weiss R, Cohen J, Sayej W, Hyams J. Preoperative immunosuppression is not associated with increased postoperative complications following colectomy in children with colitis. J Pediatr Gastroenterol Nutr. 2012 Oct; 55(4):421-4.
-
Huang H, Chikazu D, Voznesensky OS, Herschman HR, Kream BE, Drissi H, Pilbeam CC. Parathyroid hormone induction of cyclooxygenase-2 in murine osteoblasts: role of the calcium-calcineurin-NFAT pathway. J Bone Miner Res. 2010 Apr; 25(4):819-29.